Abstract : Hemophilia sufferers' life expectancy is lower than that of a healthy person due to severe bleeding, particularly cerebral hemorrhage. The current study set out to describe how these individuals presented clinically in Duhok, Iraq, and to compare their primary problems to those of comparable hemophilic patients around the globe. All enrolled patients had a full history and physical examination, in addition to coagulation investigation including prothrombin time (PT), activated partial thromboplastin time (APTT), immediate and after 2 hours incubation correction study, and factor assay accordingly (An APTT-based assay). The current study included 80 hemophiliac patients, with a median age of 15 years. The most prevalent age group was 11- 20 years. 77.5% of patients (62 patients) have family history and the remaining 22.5% of patients (18 patients) have no prior family history. The main initial clinical presentation included skin and mucous membranes bleeding. No factor VIII concentrate provided for prophylactic therapy and no inhibitor found among the enrolled patients. Most common chronic complication included joint complication (targeted joint) seen in 56 individuals (70%) and predominantly involved the knee, elbow, and ankle joints. Other complication includes viral infection particularly HBV (4/80, 5%) and HCV (8/40, 10%) infection. HIV infection not documented among the enrolled patients. Our hemophilic patients are younger than hemophiliacs worldwide, despite a reduced prevalence of the infectious agent and a complete lack of inhibitors. Prophylactic therapy in particular is required to increase the lifespan of these hemophilic people in the area.